COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS
    3.
    发明申请
    COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS 审中-公开
    用于治疗炎症性疾病的组合

    公开(公告)号:US20100056552A1

    公开(公告)日:2010-03-04

    申请号:US12450536

    申请日:2008-03-31

    申请人: Johan Raud

    发明人: Johan Raud

    摘要: There is provided combination products comprising (a) suplatast, or a pharmaceutically-acceptable salt or solvate thereof; and (b) a statin, or a pharmaceutically-acceptable salt or solvate thereof. Such combination products find particular utility in the treatment of atherosclerosis and related conditions.

    摘要翻译: 提供了包含(a)suplatast或其药学上可接受的盐或溶剂合物的组合产品; 和(b)他汀类或其药学上可接受的盐或溶剂合物。 这种组合产品在治疗动脉粥样硬化和相关病症方面具有特别的用途。

    COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS
    5.
    发明申请
    COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS 审中-公开
    用于治疗炎症性疾病的组合

    公开(公告)号:US20100168137A1

    公开(公告)日:2010-07-01

    申请号:US12448323

    申请日:2007-12-18

    申请人: Johan Raud

    发明人: Johan Raud

    摘要: There is provided combination products comprising (a) pemirolast, or a pharmaceutically-acceptable salt or solvate thereof; and (b) ramatroban, or a pharmaceutically-acceptable salt or solvate thereof. Such combination products find particular utility in the treatment of atherosclerosis and related conditions.

    摘要翻译: 提供了组合产品,其包含(a)普瑞司特或其药学上可接受的盐或溶剂合物; 和(b)拉米托班或其药学上可接受的盐或溶剂化物。 这种组合产品在治疗动脉粥样硬化和相关病症方面具有特别的用途。

    Use of compounds as antibacterial agents
    6.
    发明授权
    Use of compounds as antibacterial agents 失效
    使用化合物作为抗菌剂

    公开(公告)号:US06593339B1

    公开(公告)日:2003-07-15

    申请号:US09673007

    申请日:2000-09-29

    申请人: Arne Eek Johan Raud

    发明人: Arne Eek Johan Raud

    IPC分类号: A61K314439

    摘要: The present invention discloses a new use of NO-releasing NSAIDs, especially NO-releasing NSAIDs of the formula I, or a pharmaceutically acceptable salt or enantiomer thereof, for the manufacture of a medicament for the treatment of bacterial infections, especially caused or mediated by Helicobacter pylon. Disclosed is also the new use of a NO-releasing NSAID in combination with an acid susceptible proton pump inhibitor for the treatment of bacterial infections.

    摘要翻译: 本发明公开了用于制备用于治疗细菌感染的药物的新的用途,所述NSAID特别是NO释放的NSAID,特别是式I的NO释放的NSAID或其药学上可接受的盐或对映异构体用于治疗特别是由 幽门螺杆菌。公开也是释放NSAID与酸敏感质子泵抑制剂联合治疗细菌感染的新用途。